Other studies focused on a subgroup of B-cell precursor (BCP) ALL patients with a distinct gene expression profile, including a point variant of IKZF1 affecting the DBDs [94,95]. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.